Latest Breaking News On - Bill malkes - Page 1 : comparemela.com

NellOne s Bem Culiat, a former ORNL molecular geneticist, is trying to get FDA approval for clinical trials on a new drug for COVID-19 long haulers.

Oak ridgeUnited statesCarolyn krauseNellone therapeutics incDrug administration coronavirus treatment acceleration programOak ridge national laboratoryBrookings instituteNational science foundationTennessee small business innovation researchBone therapeuticsBig pharmaDrug administrationCoronavirus treatment accelerationNellone therapeuticsBill malkes